OtoNexus - About the company
OtoNexus is a series C company based in Seattle (United States), founded in 2010 by Caitlin Cameron. It operates as a Developer of ultrasound device to non-invasively detect middle ear infections. OtoNexus has raised $34.8M in funding from Keiretsu Capital and Mindshift Capital. The company has 36 active competitors, including 11 funded and 2 that have exited. Its top competitors include companies like TympaHealth, 3NT Medical and Lantos.
Company Details
Developer of an ultrasound device to non-invasively detect middle ear infections or Otitis Media in both children and adults. The doctor points the device at the eardrum, the device then sends an ultrasound signal that detects if fluid is present behind the eardrum, and if so, what type. Currently, doctors often suggest waiting for 24-48 hours to see if the problem resolves before prescribing antibiotics. According to the founder, OtoNexus's handheld doppler ultrasound will eliminate the need to wait.
- Website
- otonexus.com
- Email ID
- *****@otonexus.com
Key Metrics
Founded Year
2010
Location
Seattle, United States
Stage
Series C
Total Funding
$34.8M in 15 rounds
Latest Funding Round
Investors
Ranked
2nd among 36 active competitors
Employee Count
22 as on Aug 31, 2026
Similar Companies
Sign up to download OtoNexus' company profile
OtoNexus's funding and investors
OtoNexus has raised a total funding of $34.8M over 15 rounds. Its first funding round was on Jun 01, 2012. Its latest funding round was a Grant (prize money) round on Sep 09, 2025 for $*****. 1 investor participated in its latest round. OtoNexus has 23 institutional investors.
Here is the list of recent funding rounds of OtoNexus:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 09, 2025 | 2532787 | Grant (prize money) | 1207874 | 6016824 | 9050541 | 4038132 |
Oct 20, 2022 | 4719116 | Series C | 8540415 | 1267331 | 5707773 | 2301180 |
Dec 30, 2021 | 5299065 | Series C | 5904499 | 2062755 | 3783619 | 3792514 |
View details of OtoNexus's funding rounds and investors
OtoNexus' founders and board of directors
Founder? Claim ProfileThe founders of OtoNexus is Caitlin Cameron. Caitlin Cameron is the CEO of OtoNexus.
Here are the details of OtoNexus' key team members:
- Caitlin Cameron: Co-Founder & CEO of OtoNexus. Contact Info: 1 email address
View details of OtoNexus's Founder profiles and Board Members
OtoNexus' employee count trend
OtoNexus has 22 employees as of Aug 26. Here is OtoNexus's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OtoNexus's Competitors and alternates
Top competitors of OtoNexus include TympaHealth, 3NT Medical and Lantos. Here is the list of Top 10 competitors of OtoNexus, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | TympaHealth 2019, London (United Kingdom), Series A | Provider of an AI-based hearing health diagnosis device for medical professionals | $31M | 61/100 | |
2nd | OtoNexus 2010, Seattle (United States), Series C | Developer of ultrasound device to non-invasively detect middle ear infections | $34.8M | 56/100 | |
3rd | 3NT Medical 2012, Rosh Haayin (Israel), Series A | Sinusway device for endoscopy of the nasal cavity & paranasal sinuses | $15M | 44/100 | |
4th | Lantos 2009, Derry (United States), Deadpooled | Provider of 3D digital ear canal scanners | $52.3M | 43/100 | |
5th | WiscMed 2015, Middleton (United States), Series A | Developer of an otoscope for an ear infection | $8.52M | - | 41/100 |
6th | CellScope 2010, San Francisco (United States), Series A | In-ear visibility using mobile device for at-home diagnosis | $4.62M | 39/100 | |
7th | ![]() Clearwater Clinical 2005, Ottawa (Canada), Series A | Provider of assistive hardware devices for hearing | $8M | 38/100 | |
8th | Tympany Medical 2016, Galway (Ireland), Seed | Designing and developing a novel combined access and visualization device | $3.95M | 37/100 | |
9th | Audioptics Medical 2016, Halifax (Canada), Seed | Developer of diagnostic devices for ear-related diseases | $1.56M | 36/100 | |
10th | Developer of devices for the diagnosis of human and animal ear diseases | $2.14M | 35/100 |
Looking for more details on OtoNexus's competitors? Click here to see the top ones
OtoNexus's Investments and acquisitions
OtoNexus has made no investments or acquisitions yet.
Reports related to OtoNexus
Here is the latest report on OtoNexus's sector:
News related to OtoNexus
Media has covered OtoNexus for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
Meet the Most Valued Companies of the Summer Investor Capital Expo 2026LinkedIn•Aug 24, 2026•OtoNexus
•
OtoNexus Medical Technologies Ranks #4 on Puget Sound Business Journal's Best Workplaces 2025PR Newswire•Oct 15, 2025•OtoNexus
•
OtoNexus Medical Technologies - Innovative Medical Solutions Solutions/Service CompanyMedical Tech Outlook•Aug 03, 2023•OtoNexus
•
•
OtoNexus Medical Technologies Wins 2020 Red Herring Top 100 North America AwardPR Newswire•Nov 20, 2020•OtoNexus
•
•
OtoNexus Medical Technologies Receives 4th Consecutive Funding Round from Keiretsu CapitalPR Newswire•Jul 09, 2020•OtoNexus, Keiretsu Capital
•
OtoNexus Wins Keiretsu Angel Capital Expo “Most Valued Company” AwardBusiness Wire•Oct 31, 2019•OtoNexus
•
New Ultrasound Sensor Aids Middle-Ear Infection DiagnosisMedical Product Outsourcing•Sep 03, 2019•Fraunhofer, OtoNexus
•
Are you a Founder ?
FAQs about OtoNexus
Explore our recently published companies
- TRAINCONST - Chennai based, 2001 founded, Unfunded company
- Turbo Magic - Kyiv based, Unfunded company
- Comportal - Kazakhstan based, Unfunded company
- Brisk Business - 2013 founded, Unfunded company
- Istok Audio - Unfunded company
- SP SEARCH - Issy-les-Moulineaux based, 2003 founded, Unfunded company
